Related Experiment Videos
[The anti-synthetase syndrome]
C Bergoin1, M Bure, J Y Tavernier
1Clinique des Maladies Respiratoires, Hôpital A. Calmette, CHRU Lille Cedex 59037, France.
Revue Des Maladies Respiratoires
|August 6, 2002
Summary
Anti-synthetase syndrome, a rare autoimmune disorder, involves muscle inflammation, lung disease, and characteristic skin findings. Early diagnosis and immunosuppressive treatment, including corticosteroids, improve patient outcomes.
Area of Science:
- Rheumatology
- Pulmonology
- Immunology
Background:
- Anti-synthetase syndrome is a rare autoimmune condition characterized by a specific constellation of clinical and biological features.
- Key features include inflammatory myopathy, interstitial pneumonitis, mechanic's hands, Raynaud's phenomenon, inflammatory polyarthritis, and anti-synthetase antibodies.
Observation:
- This report details two male patients, aged 49 and 47, presenting with symptoms suggestive of anti-synthetase syndrome.
- Symptoms included exertional dyspnea, muscle weakness, arthralgia, and bilateral pulmonary crackles. One patient exhibited characteristic skin lesions.
- Radiological imaging confirmed interstitial lung disease, and pulmonary function tests revealed a restrictive pattern with impaired gas transfer.
Findings:
- Both patients tested positive for anti-Jo-1 antibodies, a hallmark of anti-synthetase syndrome.
- Elevated muscle enzymes indicated an inflammatory myopathy.
- Treatment with corticosteroids and cyclophosphamide resulted in symptomatic improvement and regression of radiological findings.
Implications:
- This case study highlights the importance of recognizing anti-synthetase syndrome, even in incomplete forms.
- Prompt diagnosis and aggressive immunosuppressive therapy can lead to significant clinical and radiological improvements.
- Further research into the pathogenesis and long-term management of anti-synthetase syndrome is warranted.